These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6138697)

  • 21. Effects of enantiomers of beta 2-agonists on ACh release and smooth muscle contraction in the trachea.
    Zhang XY; Zhu FX; Olszewski MA; Robinson NE
    Am J Physiol; 1998 Jan; 274(1):L32-8. PubMed ID: 9458798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systemic effects of formoterol and salmeterol: a dose-response comparison in healthy subjects.
    Guhan AR; Cooper S; Oborne J; Lewis S; Bennett J; Tattersfield AE
    Thorax; 2000 Aug; 55(8):650-6. PubMed ID: 10899240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of tolerance to the anti-leakage effect of formoterol in rat airways.
    Bowden JJ; Anderson GP; Lefevre PM; Sulakvelidze I; McDonald DM
    Eur J Pharmacol; 1997 Oct; 338(1):83-7. PubMed ID: 9408007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the beta 2 adrenoceptor agonist/antagonist activity of formoterol and salmeterol.
    Grove A; Lipworth BJ
    Thorax; 1996 Jan; 51(1):54-8. PubMed ID: 8658370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a highly sensitive and specific enzyme-linked immunosorbent assay (ELISA) for the detection of phenylethanolamine A in tissue and feed samples and confirmed by liquid chromatography tandem mass spectrometry (LC-MS/MS).
    Cao B; He G; Yang H; Chang H; Li S; Deng A
    Talanta; 2013 Oct; 115():624-30. PubMed ID: 24054641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolism of labetalol by animals and man.
    Martin LE; Hopkins R; Bland R
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):695-710. PubMed ID: 990152
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional antagonism with formoterol and salmeterol in asthmatic patients expressing the homozygous glycine-16 beta(2)-adrenoceptor polymorphism.
    Lipworth BJ; Dempsey OJ; Aziz I
    Chest; 2000 Aug; 118(2):321-8. PubMed ID: 10936119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is there a need for another inhalative beta(2)-agonist besides formoterol in patients with asthma?
    Matthys H
    Respiration; 2001; 68(4):432-7. PubMed ID: 11464097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
    van der Woude HJ; Winter TH; Aalbers R
    Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-performance liquid chromatographic determination of clenbuterol and cimaterol using post-column derivatization.
    Courtheyn D; Desaever C; Verhe R
    J Chromatogr; 1991 Apr; 564(2):537-49. PubMed ID: 1678745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low dose formoterol administration improves muscle function in dystrophic mdx mice without increasing fatigue.
    Harcourt LJ; Schertzer JD; Ryall JG; Lynch GS
    Neuromuscul Disord; 2007 Jan; 17(1):47-55. PubMed ID: 17134898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dextromethorphan: radioimmunoassay and pharmacokinetics in the dog.
    Dixon R; Carbone JJ; Mohacsi E; Perry C
    Res Commun Chem Pathol Pharmacol; 1978 Nov; 22(2):243-55. PubMed ID: 734214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Formoterol in the treatment of nocturnal asthma.
    Maesen FP; Smeets JJ; Gubbelmans HL; Zweers PG
    Chest; 1990 Oct; 98(4):866-70. PubMed ID: 1976487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mass balance and metabolism of [(3)H]Formoterol in healthy men after combined i.v. and oral administration-mimicking inhalation.
    Rosenborg J; Larsson P; Tegnér K; Hallström G
    Drug Metab Dispos; 1999 Oct; 27(10):1104-16. PubMed ID: 10497135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bronchodilator response to albuterol after regular formoterol and effects of acute corticosteroid administration.
    Lipworth BJ; Aziz I
    Chest; 2000 Jan; 117(1):156-62. PubMed ID: 10631214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Attenuation of age-related muscle wasting and weakness in rats after formoterol treatment: therapeutic implications for sarcopenia.
    Ryall JG; Schertzer JD; Lynch GS
    J Gerontol A Biol Sci Med Sci; 2007 Aug; 62(8):813-23. PubMed ID: 17702871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the protective effect of formoterol and of salmeterol against exercise-induced bronchospasm when given immediately before a cycloergometric test.
    Ferrari M; Segattini C; Zanon R; Bertaiola M; Balestreri F; Brotto E; Lo Cascio V
    Respiration; 2002; 69(6):509-12. PubMed ID: 12457003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of neutrophil and eosinophil adhesion to venules of rat trachea by beta 2-adrenergic agonist formoterol.
    Bowden JJ; Sulakvelidze I; McDonald DM
    J Appl Physiol (1985); 1994 Jul; 77(1):397-405. PubMed ID: 7525529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simultaneous measurement of Ca2+ transients and changes in the cell volume and microviscosity of the plasma membrane in smooth muscle cells. Evaluation of the effect of formoterol.
    Ochsner M
    Biochem Pharmacol; 1996 Jul; 52(1):49-63. PubMed ID: 8678908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. (-)-formoterol, a selective beta 2-adrenoreceptor agonist.
    Kurihara H; Fujita S; Mase T
    Acta Crystallogr C; 1997 Dec; 53 ( Pt 12)():1887-9. PubMed ID: 9431660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.